Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer-Reference-Cited by-同舟云学术

Comprehensive analysis and experimental validation reveal elevated CLCN4 is a promising biomarker in endometrial cancer

Published:2023-09-05 Issue:17 Volume:15 Page:8744-8769
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Wang Chenyang¹²,Li Jing³,Liu Weina¹²,Li Shiya¹²,Zhang Yi⁴,Jin Yanbin⁵,Cui Jinquan¹²

Affiliation:

1. Department of Gynecology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China

2. Academy of Medical Sciences, Zhengzhou University, Zhengzhou 450000, China

3. Department of Gynecology, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, Shandong 266000, China

4. Department of Gynecology, The University of Auckland, Grafton, Auckland 1023, New Zealand

5. Department of Gynecology, Hainan Affiliated Hospital of Hainan Medical University (Hainan General Hospital), Haikou 570311, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference73 articles.

1. Cancer Statistics, 2021.;Jemal;CA Cancer J Clin,2021

2. Cancer statistics, 2016.;Jemal;CA Cancer J Clin,2016

3. Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis.;Wentzensen;JAMA Intern Med,2018

4. Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers.;Wentzensen;J Clin Oncol,2019

5. Increased Incidence of Endometrial Cancer Following the Women's Health Initiative: An Assessment of Risk Factors.;Goldstein;J Women’s Health (Larchmt),2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study;BMC Cancer;2024-08-27